Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids

Early reduction in proteinuria is a key predictor of improved long-term kidney health in lupus nephritis (LN). In this episode, Dr. Anna Wolska from the Lupus Foundation of America speaks with Drs. Maria Dall'Era and Anca Askanase about a new propensity analysis comparing voclosporin-based triple immunosuppressive therapy to traditional high-dose glucocorticoid regimens. They discuss findings from the AURA-LV and AURORA 1 studies, highlighting the safety benefits and earlier proteinuria reduction seen with voclosporin. Tune in to explore how these insights may shape LN treatment guidelines and improve patient outcomes. Read the paper published in LSM:

You can listen to Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids online on Radio and Podcast. Open the player on this page to stream the available audio.

Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids is an episode from Lupus Science and Medicine podcast by BMJ Group.

This episode is 45:40 long.

This episode was published on Feb 3, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Lupus Science and Medicine podcast when more episodes are available from the podcast feed.